Trial Profile
A trial of bevacizumab for recurrent glioblastoma, observations on patient outcome in the Belgian Medical Need Program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 08 Dec 2015 New trial record